1-8 of 8
Harry Ostrer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract PO4-19-06: Phase II study of a PARP inhibitor, talazoparib, in HER2- metastatic breast cancer with a somatic BRCA1/2 mutation present in cell-free DNA or tumor tissue genotyping

Neelima Vidula, Senthil Damodaran, Manali Bhave, Hope Rugo, Ami N. Shah, Erica Blouch, Nathan Royce Ruffle-Deignan, Ogadinma Ogbenna, Lisa E. Flaum, Massimo Cristofanilli, Joseph Sparano, Harry Ostrer, Vandana Abramson, Nora Horick, Aditya Bardia
Journal: Cancer Research
Cancer Res (2024) 84 (9_Supplement): PO4-19-06.
https://doi.org/10.1158/1538-7445.SABCS23-PO4-19-06
Published: 02 May 2024
View articletitled, Abstract PO4-19-06: Phase II study of a PARP inhibitor, talazoparib, in HER2- metastatic breast cancer with a somatic BRCA1/2 mutation present in cell-free DNA or tumor tissue genotyping
Journal Articles

Abstract OT1-11-01: Phase II study of talazoparib, a PARP inhibitor, in somatic BRCA1/2 mutant metastatic breast cancer identified by cell-free DNA or tumor tissue genotyping

Neelima Vidula, Senthil Damodaran, Erica L. Blouch, Nora Horick, Nathan Royce Ruffle-Deignan, Manali Bhave, Ami N. Shah, Leticia Varella, Vandana Abramson, Joseph Sparano, Leif Ellisen, Ishraq Alim, Harry Ostrer, Hope Rugo, Aditya Bardia
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT1-11-01.
https://doi.org/10.1158/1538-7445.SABCS22-OT1-11-01
Published: 01 March 2023
View articletitled, Abstract OT1-11-01: Phase II study of talazoparib, a PARP inhibitor, in somatic BRCA1/2 mutant metastatic breast cancer identified by cell-free DNA or tumor tissue genotyping
Journal Articles

Abstract OT2-24-03: Phase II study of a PARP inhibitor in metastatic breast cancer with somaticBRCA1/2mutations identified by cell-free DNA: Genotyping based clinical trial

Neelima Vidula, Erica Blouch, Erin Basile, Nathan Royce Ruffle-Deignan, Nora Horick, Senthil Damodaran, Alvaro Moreno Aspitia, Manali Bhave, Ami Shah, Minetta C. Liu, Joseph Sparano, Harry Ostrer, Hope Rugo, Leif W. Ellisen, Aditya Bardia
Journal: Cancer Research
Cancer Res (2022) 82 (4_Supplement): OT2-24-03.
https://doi.org/10.1158/1538-7445.SABCS21-OT2-24-03
Published: 15 February 2022
View articletitled, Abstract OT2-24-03: Phase II study of a PARP inhibitor in metastatic breast cancer with somaticBRCA1/2mutations identified by cell-free DNA: Genotyping based clinical trial
Journal Articles

Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression

Amy E. Rose, Laura Poliseno, Jinhua Wang, Michael Clark, Alexander Pearlman, Guimin Wang, Eleazar C. Vega y Saenz de Miera, Ratna Medicherla, Paul J. Christos, Richard Shapiro, Anna Pavlick, Farbod Darvishian, Jiri Zavadil, David Polsky, Eva Hernando, Harry Ostrer, Iman Osman
Journal: Cancer Research
Cancer Res (2011) 71 (7): 2561–2571.
https://doi.org/10.1158/0008-5472.CAN-10-2958
Published: 31 March 2011
View articletitled, Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression
Open the PDF for Integrative Genomics Identifies Molecular Alterations that Challenge the Linear Model of Melanoma Progression in another window
Includes: Supplementary data
Journal Articles

Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk

Virginia G. Kaklamani, Maureen Sadim, Alex Hsi, Kenneth Offit, Carole Oddoux, Harry Ostrer, Habibul Ahsan, Boris Pasche, Christos Mantzoros
Journal: Cancer Research
Cancer Res (2008) 68 (9): 3178–3184.
https://doi.org/10.1158/0008-5472.CAN-08-0533
Published: 01 May 2008
View articletitled, Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk
Open the PDF for Variants of the Adiponectin and Adiponectin Receptor 1 Genes and Breast Cancer Risk in another window
Journal Articles

Association between genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population

Maurice Zeegers, Humera Khan, Leo Schouten, Boukje Van Dijk, R Goldbohm, Jack Schalken, Shahin Shajahan, Alexander Pearlman, Carole Oddoux, Piet Van Den Brandt, Harry Ostrer
Journal: Cancer Research
Cancer Res (2008) 68 (9_Supplement): 3115.
Published: 01 May 2008
View articletitled, Association between genetic marker polymorphisms on chromosome 8q24 and prostate cancer in the Dutch population
Journal Articles

Combined Genetic Assessment of Transforming Growth Factor-β Signaling Pathway Variants May Predict Breast Cancer Risk

Virginia G. Kaklamani, Lisa Baddi, Junjian Liu, Diana Rosman, Sharbani Phukan, Ciarán Bradley, Chris Hegarty, Bree McDaniel, Alfred Rademaker, Carole Oddoux, Harry Ostrer, Loren S. Michel, Helen Huang, Yu Chen, Habibul Ahsan, Kenneth Offit, Boris Pasche
Journal: Cancer Research
Cancer Res (2005) 65 (8): 3454–3461.
https://doi.org/10.1158/0008-5472.CAN-04-2961
Published: 15 April 2005
View articletitled, Combined Genetic Assessment of Transforming Growth Factor-β Signaling Pathway Variants May Predict Breast Cancer Risk
Open the PDF for Combined Genetic Assessment of Transforming Growth Factor-β Signaling Pathway Variants May Predict Breast Cancer Risk in another window
Journal Articles

TβR-I(6A) Is a Candidate Tumor Susceptibility Allele

Boris Pasche, Prema Kolachana, Khedoudja Nafa, Jaya Satagopan, Ye-Guang Chen, Roger S. Lo, Dara Brener, Diana Yang, Laurie Kirstein, Carole Oddoux, Harry Ostrer, Paolo Vineis, Liliana Varesco, Suresh Jhanwar, Lucio Luzzatto, Joan Massagué, Kenneth Offit
Journal: Cancer Research
Cancer Res (1999) 59 (22): 5678–5682.
Published: 01 November 1999
View articletitled, TβR-I(6A) Is a Candidate Tumor Susceptibility Allele
Open the PDF for TβR-I(6A) Is a Candidate Tumor Susceptibility Allele in another window